[9] Darlix A, Louvel G, Fraisse J, et al. Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort. Br J Cancer. 2019,121 (12), 991–1000. [10] Hackshaw MD, Danysh HE, Henderson...
检索术语为“HER2-low”或“ERBB2-low”或“human epidermal growth factor receptor 2 low”和“breast cancer”或“breast neoplasm”和“prognosis”或“survival outcome”或“overall survival”或“disease-free survival”或“progression-free survival”。检索策略的更多详细信息见表1。
[6]Schmidt G, Gerlinger C, Juhasz-Böss I, et al. Her2-neu score as a prognostic factor for outcome in patients with triple-negative breast cancer. J Cancer Res Clin Oncol. 2016 Jun;142(6):1369-76. [7]Xu H, Han Y, Wu Y, et al. Clinicopathological Characteristics and Prognosis of...
Amplification of one such oncogene, HER2 (neu, erbB-2), in up to 35% of human breast cancers is associated with a poor prognosis but may predict response to various therapeutic modalities. FDA-approved assays are available to detect the HER2 protein receptor or the HER2 gene sequence to ...
[17]Kim MH, Kim GM, Kim JH, Kim JY, Park HS, Park S, et al.. Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older. Breast Canc...
[5] Agostinetto E, et al. HER2-Low Breast Cancer: Molecular Characteristics and Prognosis. Cancers (Basel). 2021;13(11):2824. [6] Tarantino P, et al. Abstract HER2-05: HER2-05 comprehensive genomic characterization of HER2-low breast cancer....
[15]Agostinetto E, Rediti M, Fimereli D, Debien V, Piccart M, Aftimos P, Sotiriou C, de Azambuja E. HER2-low breast cancer: molecular characteristics and prognosis. Cancers (Basel) 2021;13:2824. [16]Tarantino P, Hamilton E, Tolaney SM, Cortes J, Morganti S, Ferraro E, Marra ...
4. Agostinetto E, Rediti M, Fimereli D, et al. HER2-Low Breast Cancer: Molecular Characteristics and Prognosis. Cancers (Basel). 2021 Jun 5;13(11):2824. 5. Miglietta F, Griguolo G, Bottosso M, et al. Evolution of HER2-low expression from primary to recurrent breast cancer[J]. ...
参考文献 Chen JX; Zhou JM; Zhang HQ, et al. Conversion of ER, PR, HER2 and Ki-67 and Prognosis in breast cancer metastases to the brain. 10.21203/rs.3.rs-1692389/v1. * 本文由阿斯利康提供支持,仅供医疗专业人士参考
3.Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, et al. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol. 1997;15(8):2894–904. ...